9 completed, 2 not yet recruiting, 1 recruiting, 1 withdrawn. 3 Phase 2, 2 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Completed 1 |
| Not applicable | 2 | Completed 2 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow Treatment Failure: new trials by email Literature Review of Treatment Failure trials Research Report on Treatment Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients Regorafenib (BAY 73-4506) - Carcinoma, Hepatocellular, Hepatic Insufficien | Phase 2 | Not yet recruiting | Ju Hyun Shim | 20 | 2026-03-15 | 2026-04-07 |
| Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial Regorafenib (BAY 73-4506) - Carcinoma, Hepatocellular, Lenvatinib | Phase 2 | Not yet recruiting | Ju Hyun Shim | 24 | 2026-03-15 | 2026-04-07 |
| Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS) Carboplatin/Cisplatin -Etoposide - Atezolizumab - Small Cell Lung Cancer, Large Cell Neuroendocrine (NE) Tumors | Recruiting | Oncology Center of Biochemical Education And Research | 111 | 2025-02-20 | 2025-03-19 | |
| Unplanned Emergency Department Visits, Hospital Admission, or Death During Hospital-at-Home Care for Acute Infections Integrated ED/Hospital-at-Home Model - Hospital At Home, Emergency Service, Hospital | Completed | Chimei Medical Center | 447 | 2024-08-01 | 2026-07-22 | |
| Pre-operative Characteristics for Prediction of Supraglottic Airway Failure Using Machine Learning (ERICA) non - Anesthesia, General, Postoperative Complications | Completed | University Hospital Ulm | 44000 | 2022-12-01 | 2026-05-13 | |
| Incidence of the Treatment faIlure in Osteoporosis Osteoporosis, Treatment Failure | Completed | Centre Hospitalier Universitaire Vaudois | 415 | 2022-05-01 | 2024-03-12 | |
| DOAC ADRs Retrospective Study on Genetic Variations Drug-Related Side Effects and Adverse Reactions, Treatment Failure | Completed | Cipherome, Inc. | 210 | 2021-02-01 | 2023-02-16 | |
| The Factors Causing Treatment Failure in Children Receiving Oxygen Therapy With High-flow Nasal Cannula High-flow Nasal Cannula, Respiratory Distress | Completed | Dr. Behcet Uz Children's Hospital | 201 | 2018-10-01 | 2023-11-29 | |
| Safety and Immunogenicity Study of GX-70 in TB Patient GX-70 by electroporation - Pulmonary Tuberculoses, High Risk Factors for Relapse | Phase 1 | Withdrawn | Yonsei University | 2018-03-01 | 2019-01-11 | |
| RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia Amoxicillin - Treatment Failure, Lethargy | Not applicable | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 308 | 2018-01-01 | 2021-07-16 |
| Virologic Treatment Failure and Drug Resistance in HIV-infected Kenyan Children (RESPECT) Electronic Dose Monitoring (MEMS) - Viral Resistance, Treatment Failure | Not applicable | Completed | Rachel Vreeman, MD, MS | 499 | 2017-04-24 | 2020-07-22 |
| Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure Ritonavir-boosted lopinavir, optimized background regimens (OBRs) - HIV, AIDS | Phase 4 | Completed | Bamrasnaradura Infectious Diseases Institute | 63 | 2010-12-01 | 2013-05-13 |
| Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients Peginterferon alfa2a, Ribavirin - HIV Infections, Hepatitis C, Chronic | Phase 2 | Completed | University Hospital, Bordeaux | 17 | 2002-04-01 | 2026-05-15 |
Carcinoma, Hepatocellular (2) · Acquired Immunodeficiency Syndrome (1) · Disease Progression (1) · Drug-Related Side Effects and Adverse Reactions (1) · Dyspnea (1) · Emergencies (1) · Fractures, Bone (1) · HIV Infections (1) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Hypoxia (1) · Lethargy (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplastic Cells, Circulating (1)
Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (5) · Infections (4) · Respiratory Tract Diseases (4) · Digestive System Diseases (3) · Disease Attributes (3) · Liver Diseases (3) · Lung Diseases (3) · Neoplasms by Site (3) · Adenocarcinoma (2) · Blood-Borne Infections (2) · Carcinoma (2) · Communicable Diseases (2) · Digestive System Neoplasms (2) · Genital Diseases (2)
regorafenib (2) · Amoxicillin (1) · Carboplatin (1) · Micro-Electrical-Mechanical Systems (1) · Ribavirin (1) · peginterferon alfa-2a (1)
Ju Hyun Shim (2) · Bamrasnaradura Infectious Diseases Institute (1) · Centre Hospitalier Universitaire Vaudois (1) · Chimei Medical Center (1) · Cipherome, Inc. (1) · Dr. Behcet Uz Children's Hospital (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Oncology Center of Biochemical Education And Research (1) · Rachel Vreeman, MD, MS (1) · University Hospital Ulm (1) · University Hospital, Bordeaux (1) · Yonsei University (1)
South Korea (2) · United States (2) · Bangladesh (1) · France (1) · Germany (1) · Greece (1) · Kenya (1) · Switzerland (1) · Taiwan (1) · Thailand (1) · Turkey (Türkiye) (1)
Clifford Wang, MD (1) · Dayani Nualles-Percy, MD (1) · Didier Neau, MD-PhD (1) · Genevieve Chene, Pr (1) · Hsin M Lee, MD (1) · Ju Hyun Shim, MD PhD (1) · Krittaecho Siripassorn, MD (1) · Lubaba Shahrin, MBBS, FCPS (1) · Rachel C Vreeman, MD, MS (1)